Supplementary Table 2 from Assessment of MAGE-A Expression in Resected Non–Small Cell Lung Cancer in Relation to Clinicopathologic Features and Mutational Status of &lt;i&gt;EGFR&lt;/i&gt; and &lt;i&gt;KRAS&lt;/i&gt;